Karen A Graham MD
Medical Director, Outreach And Support Intervention Services (OASIS), Professor of Psychiatry, University of North Carolina at Chapel Hill School of Medicine
Join to View Full Profile
77 Vilcom Center Dr. Dawson HallSuite 300Chapel Hill, NC 27514
Phone+1 919-962-1401
Fax+1 919-962-7373
Dr. Graham is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Karen Graham, based in Chapel Hill, NC, is a psychiatrist specializing in schizophrenia, integrative psychiatry, and psychotic disorders. She completed her psychiatry residency at the University of North Carolina Hospitals and pursued a fellowship in integrative medicine at the University of Arizona College of Medicine-Phoenix. Her publications focus on various aspects of schizophrenia and psychotic disorders, exploring topics such as vitamin D status, metabolic effects of antipsychotics, and treatment efficacy, with several articles cited multiple times in academic circles. She has also engaged in clinical trials related to weight management and metabolic changes in patients undergoing psychiatric treatments.
Education & Training
University of Arizona College of Medicine-PhoenixFellowship, Integrative Medicine, 2016 - 2018
University of North Carolina HospitalsResidency, Psychiatry, 1998 - 2000
McMaster University Medical SchoolPsychiatry, 1990 - 1993
Michael G. DeGroote School of MedicineClass of 1993
Certifications & Licensure
NC State Medical License 1998 - 2025
VA State Medical License 1999 - 2002
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Study of Amantadine for Weight Stabilization During Olanzapine Treatment Start of enrollment: 2005 May 01
- Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine Start of enrollment: 2005 Aug 01
Publications & Presentations
PubMed
- North Carolina Healthy Active Living: Describing a Wellness Coaching Program for First-Episode Psychosis Clinics.Robert E Anderson 3rd, Karen A Graham
American Journal of Lifestyle Medicine. 2025-04-10 - 57 citationsRelationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophreniaKaren A. Graham, Richard S.E. Keefe, Jeffrey A. Lieberman, A.S. Calikoglu, K.M. Lansing
Early Intervention in Psychiatry. 2015-10-01 - 15 citationsA naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.Anne C. Kelly, Brian Sheitman, Robert M. Hamer, David C. Rhyne, Robin M. Reed
Journal of Clinical Psychopharmacology. 2014-08-01
Grant Support
- Investigation Of BMI, Etc Changes Following A Switch From OlanzapineNational Center For Research Resources2006–2008
- Amantadine For Prevention Of Weight GAIN In First Epidsode Adult Psychotic SubjNational Center For Research Resources2006–2008
- Weight GAIN With Olanzapine, Quetiapine And Risperidone In Subjects With PsychosNational Center For Research Resources2004–2006
Committees
- member, UNC Investigational Review Board
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
